We are looking for young people at least 2 years of age but under 18 to join a Crohn’s disease study to help us discover more about treating gastrointestinal disease. If you are looking for a potential new treatment option for gastrointestinal disease or gastrointestinal disease (including associated symptoms such as recurrent diarrhea, joint pain, bloody stool, chronic fatigue and/or canker sores), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.
Your child may be eligible to take part in the IBD clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited so act quickly.
